GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Laboratorio Farmaceutico Erfo SpA (FRA:RK7) » Definitions » Current Deferred Revenue

Laboratorio Farmaceutico Erfo SpA (FRA:RK7) Current Deferred Revenue : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Laboratorio Farmaceutico Erfo SpA Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Laboratorio Farmaceutico Erfo SpA's current deferred revenue for the quarter that ended in Dec. 2024 was €0.00 Mil.

Laboratorio Farmaceutico Erfo SpA Current Deferred Revenue Historical Data

The historical data trend for Laboratorio Farmaceutico Erfo SpA's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Farmaceutico Erfo SpA Current Deferred Revenue Chart

Laboratorio Farmaceutico Erfo SpA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Current Deferred Revenue
Get a 7-Day Free Trial - - - - -

Laboratorio Farmaceutico Erfo SpA Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Laboratorio Farmaceutico Erfo SpA Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Laboratorio Farmaceutico Erfo SpA's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorio Farmaceutico Erfo SpA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Laboratorio Farmaceutico Erfo SpA (FRA:RK7) » Definitions » Current Deferred Revenue
Comparable Companies
MIL:CLI XSWX:NESN XPAR:BN SHSE:603288 KHC GIS K NSE:NESTLEIND SHSE:600887 TSE:2802 SZSE:300999 LSE:ABF MKC DUB:KRZ BSP:JBSS3 HRL BOM:500825 TPE:1216 SGX:F34 BOG:NUTRESA
Traded in Other Exchanges
ERFO:Italy
Address
Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049
Website
https://www.erfo.it
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.

Laboratorio Farmaceutico Erfo SpA Headlines

No Headlines